Tara Bancroft
Stock Analyst at TD Cowen
(4.80)
# 503
Out of 4,442 analysts
270
Total ratings
49.8%
Success rate
26.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Maintained: Buy | $35 | $35.15 | -0.43% | 22 | Jun 16, 2026 | |
| KLRS Kalaris Therapeutics | Initiated Coverage: Buy | n/a | $4.47 | - | 1 | Jun 15, 2026 | |
| IRON Disc Medicine | Initiated Coverage: Buy | n/a | $70.45 | - | 13 | Jun 3, 2026 | |
| CELC Celcuity | Maintained: Buy | n/a | $90.21 | - | 13 | May 14, 2026 | |
| STRO Sutro Biopharma | Maintained: Buy | n/a | $29.19 | - | 12 | May 14, 2026 | |
| FATE Fate Therapeutics | Maintained: Hold | n/a | $2.16 | - | 13 | May 13, 2026 | |
| XNCR Xencor | Maintained: Buy | n/a | $14.08 | - | 12 | May 11, 2026 | |
| RCKT Rocket Pharmaceuticals | Maintained: Hold | n/a | $3.47 | - | 2 | May 10, 2026 | |
| LNTH Lantheus Holdings | Maintained: Buy | $85 → $105 | $106.03 | -0.97% | 19 | May 7, 2026 | |
| WHWK Whitehawk Therapeutics | Maintained: Hold | n/a | $4.38 | - | 12 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.35 | +122.22% | 19 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $14.38 | +39.08% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $53.94 | -7.30% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $51.96 | +44.34% | 15 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.61 | - | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $10.12 | +97.73% | 23 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $118.96 | -15.94% | 15 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.00 | - | 12 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $36.10 | - | 3 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.921 | - | 11 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.69 | - | 14 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20.00 | $14.56 | +37.36% | 16 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.73 | n/a | 2 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $5.90 | n/a | 3 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $17.50 | n/a | 2 | Jul 26, 2024 |
UroGen Pharma
Jun 16, 2026
Maintained: Buy
Price Target: $35
Current: $35.15
Upside: -0.43%
Kalaris Therapeutics
Jun 15, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $4.47
Upside: -
Disc Medicine
Jun 3, 2026
Initiated Coverage: Buy
Price Target: n/a
Current: $70.45
Upside: -
Celcuity
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $90.21
Upside: -
Sutro Biopharma
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $29.19
Upside: -
Fate Therapeutics
May 13, 2026
Maintained: Hold
Price Target: n/a
Current: $2.16
Upside: -
Xencor
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $14.08
Upside: -
Rocket Pharmaceuticals
May 10, 2026
Maintained: Hold
Price Target: n/a
Current: $3.47
Upside: -
Lantheus Holdings
May 7, 2026
Maintained: Buy
Price Target: $85 → $105
Current: $106.03
Upside: -0.97%
Whitehawk Therapeutics
May 7, 2026
Maintained: Hold
Price Target: n/a
Current: $4.38
Upside: -
May 6, 2026
Maintained: Buy
Price Target: $3
Current: $1.35
Upside: +122.22%
May 6, 2026
Maintained: Buy
Price Target: $20
Current: $14.38
Upside: +39.08%
May 6, 2026
Maintained: Buy
Price Target: $50
Current: $53.94
Upside: -7.30%
May 6, 2026
Maintained: Buy
Price Target: $75
Current: $51.96
Upside: +44.34%
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $25.61
Upside: -
May 5, 2026
Maintained: Buy
Price Target: $20
Current: $10.12
Upside: +97.73%
May 5, 2026
Maintained: Buy
Price Target: $100
Current: $118.96
Upside: -15.94%
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $4.00
Upside: -
Apr 1, 2026
Maintained: Buy
Price Target: n/a
Current: $36.10
Upside: -
Mar 11, 2026
Maintained: Buy
Price Target: n/a
Current: $0.921
Upside: -
Mar 10, 2026
Rated: Hold
Price Target: n/a
Current: $4.69
Upside: -
Feb 19, 2026
Maintained: Buy
Price Target: $20.00
Current: $14.56
Upside: +37.36%
Mar 14, 2025
Rated: Hold
Price Target: n/a
Current: $1.73
Upside: n/a
Aug 9, 2024
Rated: Buy
Price Target: n/a
Current: $5.90
Upside: n/a
Jul 26, 2024
Downgraded: Hold
Price Target: n/a
Current: $17.50
Upside: n/a